Stay updated on Long-acting hGH in GHD Children Clinical Trial
Sign up to get notified when there's something new on the Long-acting hGH in GHD Children Clinical Trial page.

Latest updates to the Long-acting hGH in GHD Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision note v3.4.2 added and prior notices about funding/operating status (v3.4.1) removed; no study content, eligibility criteria, outcomes, or locations are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a notice about government funding lapse and updated site status guidance; the page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary and new metadata items: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0; removed the previous QC-criteria phrasing, older 'No FEAR Act data' label, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor metadata update on the page includes added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a dedicated Locations section and Florida as a trial site; removed the prior 'Florida Locations' entry along with the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page now shows Revision: v3.3.2 where it previously showed Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Long-acting hGH in GHD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-acting hGH in GHD Children Clinical Trial page.